However, the overall survival rate of patients with high expression of IFNAR1 was significantly longer than that of patients with low expression of IFNAR1 patients, which proves that IFNAR1 may be closely related to the immunotherapy of ccRCC patients. The gene discussed is IFNAR1; the disease is nonpapillary renal cell carcinoma.